Market Quotes

  Symbol List | Markets Home | Economic Calendar
Dow ▲ 17,757.91 (+138.40)
7/1/2015 4:41pm
Nasdaq ▲ 5013.12 (+26.26)
7/1/2015 5:15pm
S&P 500 ▲ 2077.42 (+14.31)
7/1/2015 4:41pm
10 Year Bond ▲ 2.42 (+0.08)
7/1/2015 2:59pm
Rigel Pharmaceuticals, Inc. (RIGL) - Quote and News
▼ 3.14 (-0.07) -2.18%

Open: 3.17
High: 3.35
Low: 3.08
Afterhours: N/A
Volume: 867913
EPS: -0.99 (Current Year Estimated: -0.85)

Technicals:
52 Week Range: 1.56 - 5.20
50 Day Moving Average: 3.55
200 Day Moving Average: 3.20
Pivot Point (Next Trading Session): 3.19

Last updated on 7/1/2015 4:00pm

Resources:

Yahoo! Discussion Board
Research Reports
Options
Analist Estimates
SEC Filings
Major Holders
Insider Activity

News:

RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
Wed, 01 Jul 2015 20:18:12 GMT


Rigel Welcomes Keith A. Katkin to Board of Directors
Tue, 30 Jun 2015 11:44:03 GMT
[at noodls] - SOUTH SAN FRANCISCO, Calif., June 30, 2015 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Keith A. Katkin, president and chief executive officer of Avanir Pharmaceuticals, ...

Rigel Welcomes Keith A. Katkin to Board of Directors
Tue, 30 Jun 2015 11:30:00 GMT
[PR Newswire] - "Keith's background in directing product launches and his successful leadership of Avanir through a growth period, will be valuable to Rigel's transition into a commercial stage company," said Raul R. Rodriguez, president and chief executive officer of Rigel. "We look forward to Keith's insights and counsel as we prepare to move fostamatinib to market in the foreseeable future," he added.

Rigel to Present at Jefferies 2015 Global Healthcare Conference
Thu, 28 May 2015 11:46:05 GMT
[at noodls] - SOUTH SAN FRANCISCO, Calif., May 28, 2015 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, is scheduled ...

Rigel to Present at Jefferies 2015 Global Healthcare Conference
Thu, 28 May 2015 11:30:00 GMT
[PR Newswire] - SOUTH SAN FRANCISCO, Calif., May 28, 2015 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, is scheduled ...

RIGEL PHARMACEUTICALS INC Financials
Sat, 16 May 2015 17:04:26 GMT


RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Fri, 15 May 2015 21:21:48 GMT


10-Q for Rigel Pharmaceuticals, Inc.
Sun, 10 May 2015 00:09:44 GMT


Rigel reports 1Q loss
Thu, 07 May 2015 23:52:09 GMT


Rigel reports 1Q loss
Thu, 07 May 2015 23:52:09 GMT


RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
Thu, 07 May 2015 20:51:59 GMT


RIGEL PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
Thu, 07 May 2015 20:32:29 GMT


Rigel Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
Thu, 07 May 2015 20:30:00 GMT


Rigel Announces First Quarter 2015 Financial Results
Thu, 07 May 2015 20:28:37 GMT
[at noodls] - SOUTH SAN FRANCISCO, Calif., May 7, 2015 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the first quarter ended March 31, 2015. ... This is an abstract of ...

Rigel Announces First Quarter 2015 Financial Results
Thu, 07 May 2015 20:05:00 GMT
[PR Newswire] - SOUTH SAN FRANCISCO, Calif., May 7, 2015 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the first quarter ended March 31, 2015. For the first quarter of ...

Q1 2015 Rigel Pharmaceuticals Inc Earnings Release - After Market Close
Thu, 07 May 2015 11:07:13 GMT


Rigel Pharmaceuticals (RIGL) Shares March Higher, Can It Continue? - Tale of the Tape
Thu, 30 Apr 2015 12:50:12 GMT


Rigel Announces Conference Call and Webcast to Report First Quarter 2015 Financial Results and Pipeline Update
Thu, 30 Apr 2015 11:56:21 GMT
[at noodls] - SOUTH SAN FRANCISCO, Calif., April 30, 2015 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its first quarter 2015 financial results after market close on ...

Rigel Announces Conference Call and Webcast to Report First Quarter 2015 Financial Results and Pipeline Update
Thu, 30 Apr 2015 11:30:00 GMT
[PR Newswire] - SOUTH SAN FRANCISCO, Calif., April 30, 2015 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its first quarter 2015 financial results after market close on ...

Calico taps space, aging research deal with Buck Institute
Tue, 28 Apr 2015 18:47:57 GMT


The Zacks Analyst Blog Highlights: Rigel Pharmaceuticals, Exelixis and Atlas Resource Partners - Press Releases
Mon, 20 Apr 2015 13:30:01 GMT


3 Momentum Picks Under $10 to Sail the Turbulent Market - Analyst Blog
Fri, 17 Apr 2015 15:57:03 GMT


Can the Rally in Rigel Pharmaceuticals (RIGL) Shares Continue? - Tale of the Tape
Thu, 09 Apr 2015 13:07:01 GMT


5 stocks to watch
Wed, 01 Apr 2015 17:54:44 GMT


Rigel Pharmaceuticals (RIGL) Looks Good: Stock Up 6.6% - Tale of the Tape
Wed, 01 Apr 2015 12:30:12 GMT


Should Rigel Pharmaceuticals (RIGL) Be On Your Radar Now? - Tale of the Tape
Thu, 26 Mar 2015 12:53:12 GMT


Why Rigel Pharmaceuticals (RIGL) Could Be Positioned for a Surge? - Tale of the Tape
Mon, 23 Mar 2015 12:53:12 GMT


Rigel Announces Fourth Quarter and Year End 2014 Financial Results
Tue, 10 Mar 2015 19:45:17 GMT
[at noodls] - SOUTH SAN FRANCISCO, Calif., March 3, 2015 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the fourth quarter and year ended December 31, 2014. For the fourth ...

Rigel reports 4Q loss
Tue, 03 Mar 2015 12:54:35 GMT


BUZZ-U.S. STOCKS ON THE MOVE-Boeing, Digital Ally, Home Loan Servicing
Mon, 23 Feb 2015 15:13:25 GMT


BUZZ-U.S. STOCKS ON THE MOVE-Rigel, oil stocks, Boeing
Mon, 23 Feb 2015 14:30:57 GMT


Rigel and Bristol-Myers Squibb Announce Research and Development Collaboration for TGF Beta Receptor Kinase Inhibitors for Use in Immuno-Oncology Related Indications
Mon, 23 Feb 2015 13:23:27 GMT
[at noodls] - SOUTH SAN FRANCISCO, Calif. and NEW YORK, February 23, 2015 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) and Bristol-Myers Squibb Company (NYSE: BMY) today announced that they have entered ...

Rigel and Bristol-Myers Squibb Announce Research and Development Collaboration for TGF Beta Receptor Kinase Inhibitors for Use in Immuno-Oncology Related Indications
Mon, 23 Feb 2015 13:21:04 GMT
[at noodls] - Dateline: SOUTH SAN FRANCISCO, Calif. & NEW YORK "This collaboration places our TGF beta receptor kinase inhibitor program into the hands of Bristol-Myers Squibb, a premier immuno-oncology company. ...

Rigel to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Thu, 08 Jan 2015 12:57:10 GMT
[at noodls] - SOUTH SAN FRANCISCO, Jan. 8, 2015 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, will present updated ...

Rigel Announces Executive Management Changes
Mon, 24 Nov 2014 12:44:03 GMT
[at noodls] - SOUTH SAN FRANCISCO, Calif., Nov. 24, 2014 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced James M. Gower is retiring from the board of directors and from his positions as chairman ...

Rigel posts 3Q loss
Tue, 04 Nov 2014 14:37:01 GMT


Rigel Announces Third Quarter 2014 Financial Results
Tue, 04 Nov 2014 13:20:38 GMT
[at noodls] - News Release SOUTH SAN FRANCISCO, Calif., Nov. 4, 2014 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the third quarter and nine months ended September 30, ...



Data is Powered by Yahoo! Finance




Interactive RIGL Charts
Yahoo! | Google | StockCharts
Market data may be delayed and is not guaranteed accurate.